MetaTOC stay on top of your field, easily

Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?

, , , , , , ,

Therapeutic Advances in Hematology

Published online on

Abstract

Therapeutic Advances in Hematology, Volume 17, January-December 2026.
SummaryWhat is this study about?Type 1 plasminogen deficiency (PLGD-1 for short) is a long-term, ultra-rare condition where the body does not make enough of a protein called plasminogen. This can cause thick layers made of a fibrous, insoluble protein ...